180 related articles for article (PubMed ID: 16503493)
1. Adenoviral infections in hematopoietic stem cell transplantation.
Leen AM; Bollard CM; Myers GD; Rooney CM
Biol Blood Marrow Transplant; 2006 Mar; 12(3):243-51. PubMed ID: 16503493
[TBL] [Abstract][Full Text] [Related]
2. T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.
Leen AM; Myers GD; Bollard CM; Huls MH; Sili U; Gee AP; Heslop HE; Rooney CM
Ann N Y Acad Sci; 2005 Dec; 1062():104-15. PubMed ID: 16461793
[TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy with virus-specific T cells.
Fuji S; Kapp M; Grigoleit GU; Einsele H
Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
[TBL] [Abstract][Full Text] [Related]
4. Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation.
Ip W; Silva JMF; Gaspar H; Mitra A; Patel S; Rao K; Chiesa R; Amrolia P; Gilmour K; Ahsan G; Slatter M; Gennery AR; Wynn RF; Veys P; Qasim W
Cytotherapy; 2018 Jun; 20(6):830-838. PubMed ID: 29753677
[TBL] [Abstract][Full Text] [Related]
5. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
[TBL] [Abstract][Full Text] [Related]
6. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
Grimley MS; Chemaly RF; Englund JA; Kurtzberg J; Chittick G; Brundage TM; Bae A; Morrison ME; Prasad VK
Biol Blood Marrow Transplant; 2017 Mar; 23(3):512-521. PubMed ID: 28063938
[TBL] [Abstract][Full Text] [Related]
7. First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation.
Geyeregger R; Freimüller C; Stemberger J; Artwohl M; Witt V; Lion T; Fischer G; Lawitschka A; Ritter J; Hummel M; Holter W; Fritsch G; Matthes-Martin S
J Immunother; 2014 May; 37(4):245-9. PubMed ID: 24714358
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral infections in pediatric transplant recipients: a hospital-based study.
de Mezerville MH; Tellier R; Richardson S; Hébert D; Doyle J; Allen U
Pediatr Infect Dis J; 2006 Sep; 25(9):815-8. PubMed ID: 16940840
[TBL] [Abstract][Full Text] [Related]
9. High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation.
Schilham MW; Claas EC; van Zaane W; Heemskerk B; Vossen JM; Lankester AC; Toes RE; Echavarria M; Kroes AC; van Tol MJ
Clin Infect Dis; 2002 Sep; 35(5):526-32. PubMed ID: 12173125
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality.
George D; El-Mallawany NK; Jin Z; Geyer M; Della-Latta P; Satwani P; Garvin JH; Bradley MB; Bhatia M; van de Ven C; Morris E; Schwartz J; Cairo MS
Br J Haematol; 2012 Jan; 156(1):99-108. PubMed ID: 22008222
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery.
van Tol MJ; Kroes AC; Schinkel J; Dinkelaar W; Claas EC; Jol-van der Zijde CM; Vossen JM
Bone Marrow Transplant; 2005 Jul; 36(1):39-50. PubMed ID: 15908981
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?
Chakrabarti S; Collingham KE; Fegan CD; Pillay D; Milligan DW
Bone Marrow Transplant; 2000 Aug; 26(3):305-7. PubMed ID: 10967570
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation.
Myers GD; Bollard CM; Wu MF; Weiss H; Rooney CM; Heslop HE; Leen AM
Bone Marrow Transplant; 2007 Jun; 39(11):677-86. PubMed ID: 17417664
[TBL] [Abstract][Full Text] [Related]
14. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P
Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus as an emerging pathogen in immunocompromised patients.
Leen AM; Rooney CM
Br J Haematol; 2005 Jan; 128(2):135-44. PubMed ID: 15638847
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P
Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420
[TBL] [Abstract][Full Text] [Related]
17. Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein-Barr virus or adenovirus after allogeneic stem cell transplantation.
Feucht J; Joachim L; Lang P; Feuchtinger T
Klin Padiatr; 2013 May; 225(3):164-9. PubMed ID: 23700092
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cellular immunotherapy for viral diseases.
Fujita Y; Rooney CM; Heslop HE
Bone Marrow Transplant; 2008 Jan; 41(2):193-8. PubMed ID: 17982497
[TBL] [Abstract][Full Text] [Related]
19. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
20. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.
Leen AM; Sili U; Savoldo B; Jewell AM; Piedra PA; Brenner MK; Rooney CM
Blood; 2004 Feb; 103(3):1011-9. PubMed ID: 14525768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
